Zobrazeno 1 - 10
of 492
pro vyhledávání: '"Kiwamu OKITA"'
Publikováno v:
JGH Open, Vol 5, Iss 2, Pp 207-212 (2021)
Abstract Background and Aim Because covert hepatic encephalopathy (CHE) has been shown to affect the prognosis of cirrhotic patients, early diagnosis of hepatic encephalopathy (HE) is a prerequisite for the preservation of patients' quality of life a
Externí odkaz:
https://doaj.org/article/0a594a5be9ce4606b38d6a4a339129b0
Autor:
Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda, Takuji Torimura, Nobukazu Tanabe, Hiroshi Aikata, Namiki Izumi, Takahiro Yamasaki, Shunsuke Nojiri, Keisuke Hino, Hidetaka Tsumura, Teiji Kuzuya, Norio Isoda, Michihisa Moriguchi, Hajime Aino, Akio Ido, Naoto Kawabe, Kazuhiko Nakao, Yoshiyuki Wada, Sadahisa Ogasawara, Kenichi Yoshimura, Takuji Okusaka, Junji Furuse, Norihiro Kokudo, Kiwamu Okita, Philip James Johnson, Yasuaki Arai
Publikováno v:
Liver Cancer (2022)
Introduction Several clinical trials comparing the efficacy and safety of transarterial chemoembolisation (TACE) plus molecular-targeted agents versus TACE alone revealed no clinical benefits in progression-free survival (PFS) or overall survival (OS
Externí odkaz:
https://doaj.org/article/cc83eaff16bc4510925c92f9ce0993dd
Autor:
Hideto Kawaratani, Hisamitsu Miyaaki, Atsushi Hiraoka, Kazuhiko Nakao, Yoichi Hiasa, Hitoshi Yoshiji, Kiwamu Okita, Kazuhiko Koike
Publikováno v:
Medicina, Vol 58, Iss 6, p 741 (2022)
Background and Objectives: Sleep disturbance due to muscle cramps or hepatic encephalopathy in patients with chronic liver disease (CLD) can lead to a reduced quality of life. The Pittsburgh sleep quality index (PSQI) is commonly used for evaluating
Externí odkaz:
https://doaj.org/article/014b9b5e870a41208caeb7a94aa1e9fd
Autor:
Hitoshi Shirahashi, Jian Wu, Naoki Yamamoto, Andreea Catana, Henning Wege, Brook Wager, Kiwamu Okita, Mark A. Zern M.D.
Publikováno v:
Cell Transplantation, Vol 13 (2004)
Embryonic stem (ES) cells may differentiate along a hepatocyte lineage; however, currently there are no reports of culture conditions yielding high levels of hepatocyte-specific gene expression in these cells. We investigated culture conditions for d
Externí odkaz:
https://doaj.org/article/8189a1f0d15f4781a5eadec6c16c9a1d
Autor:
Yuta Fujise, Shoichi Hazama, Toshiyuki Fujii, Motoshige Inoue, Shotaro Takahashi, Kazuya Yoshida, Akihiko Ikeda, Hiroshi Hashiyada, Kembu Nakamoto, Aogu Yamashita, Keisuke Hino, Kiwamu Okita
Publikováno v:
Medicine; 6/21/2024, Vol. 103 Issue 25, p1-5, 5p
Autor:
Takuji Okusaka, Masatoshi Kudo, Kenji Ikeda, Masafumi Ikeda, Kiwamu Okita, Michiko Sugawara, Toshiyuki Tamai, Min Ren, Kenichi Saito, Hiromitsu Kumada
Publikováno v:
Hepatology Research. 52:784-793
The phase III REFLECT study utilized bodyweight-based lenvatinib dosing in patients with unresectable hepatocellular carcinoma, based on results of the phase II Study 202. This post hoc analysis compared efficacy and safety in patients with lower and
Autor:
Hiromitsu Kumada, Kiwamu Okita, Tadashi Kadowaki, Seiichi Hayato, Takuya Suzuki, Toshiyuki Tamai, Hideki Ueno, Shuichi Mitsunaga, Takuji Okusaka, Masafumi Ikeda
Maximum change from baseline in levels of AFP for individual patients along with their response rate (best of overall tumor response).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640ad01b81a39ae9ae2b727fa84c44fe
https://doi.org/10.1158/1078-0432.22458186
https://doi.org/10.1158/1078-0432.22458186
Autor:
Hiromitsu Kumada, Kiwamu Okita, Tadashi Kadowaki, Seiichi Hayato, Takuya Suzuki, Toshiyuki Tamai, Hideki Ueno, Shuichi Mitsunaga, Takuji Okusaka, Masafumi Ikeda
Purpose: To determine the maximum tolerable dose (MTD), safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of lenvatinib in patients with advanced hepatocellular carcinoma (HCC).Experimental Design: This multicenter, open-label, pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c653bb31e4cf7339a4a55f8d96595e9
https://doi.org/10.1158/1078-0432.c.6523860.v1
https://doi.org/10.1158/1078-0432.c.6523860.v1
Autor:
Ryosuke Ogata, Toshiyuki Fujii, Keisuke Hino, Ryouichi Tsunedomi, Hiroaki Nagano, Tokuhiro Ishihara, Toshiaki Kamei, Takeshi Nagasaka, Yosuke Nagahiro, Kazuya Yoshida, Akihiko Ikeda, Hiroshi Hashiyada, Kenbu Nakamoto, Mika Kajiyama, Aogu Yamashita, Motoshige Inoue, Kiwamu Okita, Shoichi Hazama
Background: One characteristic of Lynch syndrome, which is caused by germline mutations in a group of genes encoding mismatch repair proteins, is the early onset of colorectal cancer. Here, we report a rare case of juvenile colon cancer, diagnosed ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49cdef511fd02712814f618dca710e82
https://doi.org/10.21203/rs.3.rs-2725014/v1
https://doi.org/10.21203/rs.3.rs-2725014/v1
Publikováno v:
JGH Open, Vol 5, Iss 2, Pp 207-212 (2021)
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
Background and Aim Because covert hepatic encephalopathy (CHE) has been shown to affect the prognosis of cirrhotic patients, early diagnosis of hepatic encephalopathy (HE) is a prerequisite for the preservation of patients' quality of life and for pr